Literature DB >> 12437251

Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival.

Lorenzo Capussotti1, Andrea Muratore, Roberto Polastri, Alessandro Ferrero, Paolo Massucco.   

Abstract

BACKGROUND: Extended surgical procedures are the only chance of longterm survival for patients with Klatskin tumors, but high mortality rates have been reported. The type of treatment for Bismuth type l-II carcinomas is still a matter of discussion. STUDY
DESIGN: We performed a single-unit, retrospective study analyzing 36 patients who underwent resectional surgery for Klatskin tumor.
RESULTS: An associated liver resection was performed in 88.9% of our patients; most of them had a major hepatectomy. The in-hospital mortality rate was 2.8%. Three- and 5-year survival rates were 40.8% and 27.2%, respectively. But the group of patients with Bismuth type I-II carcinomas undergoing hepatectomy had markedly better longterm outcomes than those undergoing hilar resection (p = 0.04): 54.5% versus 0% at 5 years, respectively; none of the patients who had only resection of bile duct confluence were alive at 2 years. Lymph node metastases were found in 38.8% of our patients; nodal involvement was not a major prognostic factor.
CONCLUSIONS: Achievement of low in-hospital mortality rates is possible in specialized surgical departments. Aggressive surgical approaches can allow better longterm results in the subset of Bismuth type I-II carcinomas.

Entities:  

Mesh:

Year:  2002        PMID: 12437251     DOI: 10.1016/s1072-7515(02)01481-3

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  25 in total

1.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Outcome of surgical treatment of hilar cholangiocarcinoma.

Authors:  Kazuhiro Otani; Kazuo Chijiiwa; Masahiro Kai; Jiro Ohuchida; Motoaki Nagano; Kazuyo Tsuchiya; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

4.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

5.  Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion.

Authors:  Alastair L Young; Tsuyoshi Igami; Yoshiki Senda; Robert Adair; Shahid Farid; Giles J Toogood; K Rajendra Prasad; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2011-07       Impact factor: 3.647

Review 6.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

Review 7.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

Review 8.  Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.

Authors:  Masato Nagino
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

Review 9.  Perihilar cholangiocarcinoma: Current therapy.

Authors:  Wei Zhang; Lu-Nan Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

10.  Spiegel's lobe bile ducts often drain into the right hepatic duct or its branches: study using drip-infusion cholangiography-computed tomography in 179 consecutive patients.

Authors:  Masahiro Kitami; Gen Murakami; Saiho Ko; Kei Takase; Masahiro Tuboi; Haruo Saito; Yoshiyuki Nakajima; Shoki Takahashi
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.